Flu & Viruses
-
Five Cs’ needed to tackle vaccine hesitancy
The strategy to deal with COVID-19 vaccine hesitancy needs to focus on five Cs: confidence, complacency, convenience, communication and context, scientists say today. Read more
-
G7 to work against zoonoses
The world’s leading democracies are to work together to combat the growing threat from zoonotic infection, it was announced today. Read more
-
Call for new vaccine approach in India
Public health practitioners are calling for the Covid-19 vaccination to be provided free of charge and vaccine approvals to be hastened in India. Read more
-
Double dose vaccines effective against Indian variant
Double dose vaccination is “highly effective” against the Indian variant of COVID-19 – but not quite as effective as against other variants, British researchers have reported. Read more
-
High income countries’ excess death toll in 2020
Twenty-nine high-income countries accounted for almost one million extra deaths because of the COVID-19 pandemic in 2020, according to a new study. Read more
-
Long-term conditions in post-acute COVID-19 phase
One in seven adults with COVID-19 developed at least one new condition that required medical care during the post-acute phase of illness, a new US study has found. Read more
-
Hope for hepatitis B treatment
A new immunotherapy can combat the hepatitis B virus, researchers have reported. Read more
-
New blood group link to COVID risk
A major blood group gene is closely linked to the risk of disease from COVID-19 infection, according to a new analysis. Read more
-
Emphasise personal benefits of COVID-19 vaccine’
Emphasising the personal benefits of the COVID-19 vaccine is the best way to persuade those who resist the injection, according to a new study. Read more
-
Mixing COVID-19 vaccine increases reactions
Mixing COVID-19 vaccines increases an individual’s reactogenicity compared to standard schedules, according to preliminary data from the Com-COV study. Read more